No pain, no gain: Can pain medications reduce dementia risk?
By Chaehyeon Jin, Student Pharmacist, and Karen Kier, Pharmacist
ONU Healthwise Pharmacy
The saying “no pain, no gain” has roots in ancient Greece, when Sophocles wrote “there’s no success without pain” in his play Electra. In 1758, Ben Franklin published a book title The Way to Wealth and penned the statement, “there are no gains, without pains.” The saying took on new meaning with the aerobics craze of the 1980s when Jane Fonda’s videos pushed you to “feel the burn.”
With the pains of exercise, we could recommend over the counter (OTC) medications such as ibuprofen (Motrin®, Advil®) or naproxen (Aleve®) to help relieve pain. These drugs belong to a class of medications known as the nonsteroidal anti-inflammatory drugs, often just abbreviated as NSAIDs.
Doses of OTC NSAIDs can be helpful for treating minor pain, fever, arthritis and some inflammation. The prescription strength of the same medications can provide stronger relief from pain, inflammation and arthritis. Ask your pharmacist for help with NSAID recommendations.
Ibuprofen was FDA-approved as a prescription product in 1974 and became available as an OTC product in 1984. Since that time, we have learned more about NSAIDs use and safety. In 1997, the Baltimore Longitudinal Study in Aging was published and demonstrated an association with a reduction in dementia risk in participants who routinely took NSAIDs for more than 2 years. Other studies have been published since that time with similar results.
Why is this so important today?
The United States population is advancing in age, with more baby boomers turning 65 years old, coinciding with a reduction in birth rates. In 2020, 1 in 6 adults were over the age of 65.
As society advances, population aging has brought an emerging public health concern: dementia. This condition affects millions of individuals and their families worldwide. Researchers continue to investigate its causes and explore strategies to reduce risk.
A 2025 study, published in the Journal of the American Geriatrics Society, examined whether long-term use of NSAIDs, such as ibuprofen or naproxen, could help to reduce dementia risk.
The study followed 11,745 dementia-free adults, with an average age of 66, over approximately 14½ years. Findings revealed participants who used NSAIDs for more than 24 months experienced about a 12% lower risk of developing dementia compared to non-users. However, shorter-term use (less than two years) did not demonstrate the same benefit.
Why not recommend daily use of NSAIDs to prevent dementia? The researchers emphasized that long-term NSAID use carries potential risks, precluding it from being an ideal solution. Prolonged use may cause serious side effects, including stomach bleeding, kidney impairment, and cardiovascular issues. NSAIDs affect the ability of the blood to form a clot when you cut yourself. They can also cause irritation and bleeding from the gastrointestinal tract, which can be mild to severe.
A Cleveland Clinic study was the first to reveal some potential problems with some prescription NSAIDs involving heart disease. For more detailed guidance, contact your healthcare provider.
Currently, experts do not recommend starting NSAIDs for the prevention of dementia. Individuals who daily take NSAIDs for other medical reasons could benefit from the reduction in the risk of dementia. Always consult a healthcare provider before starting or modifying any medication.
Proven strategies to reduce dementia risk involve healthy lifestyle habits. Regular physical activity, a balanced diet, adequate sleep, mental games/puzzles, and social engagement are keys.
If NSAIDs are part of your treatment plan, pharmacists can ensure safe usage by using the lowest effective dose for the shortest time, taking it with food to protect the stomach, and checking for interactions with other medications.
With no pain from NSAID treatment, we could see a gain in the reduction of dementia.
If you are interested in more information, please contact ONU HealthWise Pharmacy at 419-722-3784.
Stories Posted This Week
Saturday, September 19, 2026
- Bulldog golf 3rd at final BVC tourney, 2nd overall
- Bulldog football win vs. Perry
- N. Main St. arrest and drug seizure on August 18
- Christian Nationalism poses problems for American democracy
- Weekend Doctor: When should you see an endocrinologist?
- Letter: Background regarding public meeting on data center moratorium
Friday, September 18, 2026
Thursday, September 17, 2026
- Bluffton Icon headlines, September 17
- Bulldog girls soccer 0-0 tie vs. Riverdale
- Bulldog boys soccer loss vs. Riverdale
- Roundhead poet publishes third book
- Bulldog volleyball wins in four vs. Riverdale
- Sept. 15 Ada Council: Impact of big ticket pool repair, public urination ban goes into effect
- Hall named 2026 OMLA Regional Administrative Assistant of the Year
- Play Bingo with Officer Penny at the Ada Public Library
- Adult Book Group books available at APL
- Ada Schools exceed state standards on 2025-2026 Ohio Report Card
- Oct. 6 ONU Trike-A-Thon will raise funds for St. Jude's
- Antibiotic resistance: More to learn
Wednesday, September 16, 2026
Tuesday, September 15, 2026
- Bicyclist injured in hit-skip accident south of Kenton
- ODOT requests public comment on roundabout design for State Route 81/County Road 15 intersection
- Anna M. Shulaw, 105, worked for Wilson Sporting Goods
- Liberty Conservation Club fish and chicken fry, Oct. 10
- Bulldog boys soccer loss vs. Fort Jennings
- Findlay Patrol's Donovan promoted to sergeant
- Bulldog girls soccer win vs. Delphos St. John’s
- 2026 Harvest & Herb Festival Queen Court announced